Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Glycans play a crucial role in regulating hair growth and follicle balance.

Glycans play a crucial role in regulating hair growth and follicle balance.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Aromatase inhibitors cause male pattern hair loss in women.

Marine-derived ingredients show potential for hair health but need more human trials to confirm effectiveness.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Hair follicle culture helps develop new treatments for hair loss.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Finasteride given to baby rats causes anxiety-like behavior and worsens learning from punishment in adult rats.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.